Healthcare costs in Singapore are rising at roughly 12 percent annually. The Basic Healthcare Sum, which sets the ceiling for what you can accumulate in Medisave, increased from S$75,500 in 2025 to S$79,000 in 2026. This sounds like progress until you ask a single question: who is actually catching up?
For Singaporeans relying on private healthcare, the answer is increasingly nobody. The structural gap between what your Medisave can cover and what private hospitals actually charge has widened from a policy inconvenience into a real financial problem. Government adjustments arrive every few years. Medical inflation arrives every quarter.
As examined in our analysis of why Singapore professionals systematically underinvest in preventive health, this pattern connects to a broader tendency to treat health spending as remediation rather than maintenance. The structural gap between Medisave accumulation and private care costs makes that underinvestment more consequential every year.
What Changed, and Why It Matters Now
The Medisave system was designed around a different healthcare landscape. When the scheme began, public and private care existed on a continuum. Today they exist in parallel, serving different patient populations with different assumptions about how much treatment should cost.
The Basic Healthcare Sum acts as the primary lever that government uses to keep pace with healthcare inflation. Raise it, and individuals can theoretically save more for future medical expenses. But the government raises it infrequently, roughly every three to five years, in tranches of a few thousand dollars. Healthcare costs do not wait for policy cycles.
Since 2004, overall healthcare costs in Singapore have increased 55.8 percent. That is an average healthcare inflation of 2.24 percent per year, a number that seems modest until you look at what has actually driven it. Labour comprises approximately 60 percent of total healthcare cost in Singapore. Specialist fees, nursing salaries, and facility management have all risen faster than general wage inflation, because healthcare demand is inelastic. People need surgery whether the economy is strong or weak.
The government has acknowledged this acceleration. From April 2025, MediShield Life premiums increased across multiple age brackets, with some groups seeing increases as high as 86.3 percent compared to 2021 rates. This is the insurance layer responding to the same pressure that is hitting hospital bills.
So what does this mean if you are a Singaporean saving for healthcare through Medisave? It means the gap between what you can accumulate and what you might actually need is no longer a theoretical exercise. It has become a planning problem.
The Real Numbers Behind the Gap
A straightforward example illustrates the arithmetic. A 45-year-old Singaporean with regular private healthcare visits might accumulate roughly S$500 to S$800 in annual Medisave contributions after mandatory CPF contributions to housing and retirement. Over 20 years, this creates a pool of approximately S$100,000 to S$160,000 in Medisave savings, assuming no withdrawals and modest interest.
A private hospitalization for a common condition like hernia repair or cataract surgery at a private hospital can cost S$8,000 to S$15,000 in total medical fees alone, depending on hospital and specialist choice. A serious condition requiring extended inpatient care with imaging, multiple specialists, and surgical intervention can easily exceed S$30,000. If the patient requires follow-up treatment, the costs compound.
The government has made targeted adjustments to the withdrawal limits. From October 2025, the Flexi-MediSave annual withdrawal limit increased from S$300 to S$400. From January 2026, the outpatient scan withdrawal limit doubled from S$300 to S$600. These changes allow individuals to draw down Medisave for more preventive and diagnostic care.
But here is the constraint that matters: you can only withdraw what you have accumulated. A person who chose private care for ten years and drew down Medisave regularly will have less in reserve when a major medical event occurs. The government’s matched contributions through the Matched MediSave Scheme, which offers dollar-for-dollar matching of voluntary top-ups for ages 55 to 70 up to S$1,000 per year, arrive late in the accumulation cycle for most people.
The government has also committed S$4.1 billion in support over three years to offset MediShield Life premium increases. This cushions the insurance layer. But insurance alone does not pay bills. Medisave does. And Medisave is the bottleneck.
Who Feels This Gap Most Acutely
The first group consists of high-income individuals who use private care consistently but have incomes above the CPF contribution ceiling. These people hit the maximum CPF contribution cap and cannot simply save more into Medisave through payroll deductions. They must choose between accumulating additional Medisave through voluntary contributions, which receive no matching, or accepting the gap and paying private bills directly from after-tax income.
The second group is working professionals in their 40s and 50s who have chosen private primary and specialist care for 15 or 20 years. They have regular Medisave withdrawals on their record. When they approach retirement and face a major medical event, their Medisave balance is lower than someone who used public care and rarely drew down. The system implicitly penalizes consistent private care use.
The third group is the growing segment of Singaporeans who can afford private care but do not have high enough incomes to absorb large out-of-pocket costs comfortably. These are professionals earning S$60,000 to S$150,000 annually who prefer private healthcare for scheduling flexibility, continuity with the same doctor, and shorter waiting times. They are caught between Medisave accumulation rates that assume public care use and private fees that have drifted upward.
As explored in our analysis of Southeast Asia’s ageing population and the longevity economy, healthcare demand across the region is structurally increasing. A comparison with regional systems clarifies the point. In Malaysia, private healthcare fees are lower, but patients also have fewer mandatory savings mechanisms. In Australia, the private insurance system operates through pure premium payments, not carved-out savings accounts. Singapore’s Medisave was designed as a hybrid solution: individuals save, the government subsidizes public care, and a safety net insurance layer covers catastrophic costs. But the hybrid only works if all three layers keep pace. Medisave is not keeping pace.
How the System Actually Works Now
Medisave contributions flow from your CPF balance. Your employer contributes a percentage of your salary, up to a ceiling, and this is split between Retirement, Housing, and Healthcare accounts. You cannot redirect these contributions; they are allocated by formula. From your salary of S$100,000, for example, roughly S$13,000 per year flows to Medisave.
You can withdraw this for four purposes: approved hospitalisation charges, approved day surgery charges, approved outpatient treatment charges, and premiums for approved healthcare insurance. The definition of “approved” is set by CPF Board and MOH. Private hospital charges that fall outside approved fee schedules are not covered, which is why the withdrawal limit is where the real constraint sits.
You can also make voluntary contributions to Medisave, up to the Basic Healthcare Sum. For 2026, this means you can maintain a balance up to S$79,000 across your Medisave account. Once you hit this ceiling, additional voluntary contributions receive no matching and no investment returns through the Medisave account. They simply accumulate, untouched, which makes them pointless for most people.
The Matched MediSave Scheme announced in the 2025 Budget changes this calculation for ages 55 to 70. The government now matches dollar-for-dollar voluntary contributions up to S$1,000 per year, enabling individuals to exceed the Basic Healthcare Sum before retirement and have an additional cushion. But this matching only applies to people within five to 15 years of retirement. For someone aged 40, the scheme offers no advantage. They are expected to rely on the standard accumulation model, which is insufficient for consistent private care use.
If you require a major medical expense and your Medisave balance is depleted, you can tap Integrated Shield Plans, which blend MediShield Life with private insurance top-ups. The cost of these plans has also increased sharply. Or you pay out-of-pocket. This is where the system separates people by income.
Regional Perspective: How Singapore Compares
Singapore has chosen to place the burden of healthcare inflation management on individuals through Medisave accumulation. Hong Kong allows direct opt-in to private insurance markets where competition has kept cost growth somewhat slower. Taiwan relies on a central insurance fund supported by progressive taxation, meaning individuals do not accumulate reserves but know they have coverage for major events. South Korea uses a combination of national insurance and employer-sponsored plans.
The difference is structural. Singapore’s model places a higher cognitive and financial load on workers to anticipate their healthcare needs 20 or 30 years in advance. The system works well for people who can afford to either save aggressively outside Medisave or rely on public care. It creates friction for everyone else. Subsidising insurance premiums is not the same as expanding the amount individuals can actually draw for care.
The Strategic Insight
The system is not broken. It is functioning as designed. Medisave was built to enable healthcare savings while encouraging use of public care, which is subsidised and therefore lower cost. The gap between Medisave and private costs is not a malfunction. It is a price signal telling you which system the government considers primary.
For individuals, this creates a choice. You can either plan to use public healthcare for major events and reserve Medisave for supplementary costs, in which case you will likely have enough. Or you can prefer private care and plan to absorb costs beyond what Medisave covers through direct payment, in which case you need to earn enough to do so comfortably. The system does not prevent either path. It simply makes one path cheaper and the other more expensive.
The Matched MediSave Scheme and adjusted withdrawal limits are not game-changers. They are marginal improvements that acknowledge the gap without closing it. They will help people who are already planning well, aged 55 or older, or earning above-ceiling incomes that allow voluntary top-ups. They will not help someone earning S$80,000 annually who wants to use private primary care consistently without worrying about Medisave depletion by age 55.
What has changed is that more Singaporeans are choosing private care earlier in life, and the cost of that choice is becoming more visible. This is the real story. Not that Medisave is inadequate in absolute terms, but that the population is gradually shifting toward healthcare consumption patterns that outpace the savings mechanism that the government built.
For the policy journalist watching this shift, the question is no longer whether Medisave keeps pace with costs. It clearly does not, and the government is not attempting to make it do so. The question is whether the government will eventually acknowledge this gap and shift policy, or whether Singaporeans will gradually absorb the cost difference through out-of-pocket spending and private insurance premiums. For now, the answer appears to be the latter.
